Viewing Study NCT05164393


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2025-12-25 @ 11:17 PM
Study NCT ID: NCT05164393
Status: UNKNOWN
Last Update Posted: 2022-01-27
First Post: 2021-11-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
Sponsor: Coegin Pharma AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module